Navigation Links
Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
Date:5/23/2008

In response to the announcement by the Federal Aviation Administration (FAA), Commit Lozenges now offered to pilots and air traffic controllers

who are quitting smoking

PITTSBURGH, May 23 /PRNewswire/ -- With the Federal Aviation Administration's (FAA) recent announcement to remove a prescription anti-smoking pill from their approved list of safe medications for pilots, GSK Consumer Healthcare, an industry leader in smoking cessation, is offering one free 48 count of 2mg or 4mg Commit Cherry lozenges to all licensed commercial and private pilots who are interested in quitting smoking today, through June 30. It is important for pilots to understand that NRT has been the recommended aid for pilots to quit smoking since 1994, and that the FAA news in no way includes GSK's products, which are deemed safe and effective medicines to relieve nicotine withdrawal symptoms that arise during a quit attempt.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/gsk/33419/

Recent clinical research has demonstrated that the Commit 4 mg lozenge reverses the negative impact that nicotine withdrawal has on the ability to concentrate, attention deficit, short-term memory and selective attention during a quit attempt(1) -- all these issues were at the core of the FAA's ruling.

"It's important that pilots interested in quitting have access to safe, evidence-based treatments," said Bill Slivka, vice president, Smoking Control, GlaxoSmithKline Consumer Healthcare. "Over the past ten years, our NRT products, including the Commit lozenge, have helped more than 6.5 million smokers around the world quit. This free offer to pilots and air traffic controllers further demonstrates our mission to help more smokers achieve their goal of safely becoming smoke-free."

The Commit lozenge give-away program is open to all U.S. residents,
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... A US Airman, fresh from basic training ...eukemia patient whose life he saved by donating hi...an Air Base, Republic of Korea (PRWEB) November 21...irman whose blood donation saved her life, met for...ov. 21, 2008. , , , , ,Airman Tamarias Pope, 8th ...
(Date:11/21/2008)..., Fla. -- A Florida State University College of Me...overed an important new layer of regulation in the...r understanding of the way cancer begins. , Wang... the College of Medicine, said the findings will l...could lead to the design of new drugs that kill ca...
(Date:11/21/2008)... Nov. 21 The Generic,P...owing statement today from,GPhA President and CEO...ssion,(FTC) roundtable on "Emerging Health Care C...e fact that the FTC is conducting this roundtable ... that consumers have access to safe and,affordabl...
(Date:11/21/2008)...a., Nov. 21 New researc...er a smokeless, spitless tobacco product aimed at ...ave found that RJ Reynolds, Camel Snus - touted as...contains surprisingly high levels of nicotine. , ...st other snuff products," said Bruce Adkins of the...
Breaking Medicine News(10 mins):Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 2Health News:Life-Saving Airman, Leukemia Patient Meet for First Time 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...ave shown inhaled corticosteroids can decrease a p... now say long-term use of ICS therapy is not assoc...teroids are commonly used to treat asthmatics and ...nary disorder. Researchers say these medications a...
... thought of rickets as a disease of the past. New ...blem and prevention should start before birth and ... vitamin D supplementation.// Rickets is a childho...kening of the bones, primarily caused by lack of v...
...ave shown breast cancer patients who receive radia...n and a mastectomy may be more likely to develop c...y not be the case. Researchers from the Fox Chase ...east cancer who underwent a mastectomy, breast rec...
...kidney patients have far more to be concerned abou...ciation-sponsored study shows //people with chroni... heart disease. Doctors say the most surprising fi...ople who are in the very early stages of kidney di...
Other Medicine News:
(Date:11/20/2008)...ember 20 The Scandinavian-based dr...ced results of studies on its,lead antimicrobial ...n, DC,the studies showed that the novel lytic pe...ect, significantly better towards killing Staphylo...keted gold standard drugs. In,addition to this it...
(Date:11/19/2008).... 19 Biotech scientists increasing...y research to better understand the effects of nov...reports Genetic Engineering & Biotechnology N...guring out a new compound,s mechanism of action an...chnique, according to the November 15 issue of GE...
(Date:11/18/2008)...PRNewswire/ -- Arlington Medical Resources (AMR), ... pharmaceutical and diagnostic,imaging industries...vigen was,sold in the U.S. during the third quart...venous immune globulin (IVIG) and was launched in ...ted from the blood plasma of thousands,of donors ...
(Date:11/13/2008)...Nutritional Supplements Prior to Surgery, ARLINGT...-- Identifying,malnutrition before surgery in mass...ill significantly decrease surgical complications,...d boost patient energy levels,according to a stud...ive,Surgery(R), the official medical journal of th...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Newt Gingrich Statement on the Loss of Tony Snow 23855 1Newt Gingrich Statement on the Loss of Tony Snow 23855 2Summer Is Peak Time for Lightning Strikes 23851 1Summer Is Peak Time for Lightning Strikes 23851 2Dramatic increase in Tommy John surgery in young patients cause for concern 23847 1Dramatic increase in Tommy John surgery in young patients cause for concern 23847 2Bioheart Inc Announces Management Change 6516 1Bioheart Inc Announces Management Change 6516 2Bioheart Inc Announces Management Change 6516 3
..., May 21, 2007 - Results from phase III,clinical t...presented at the 16th Congress of the European Aca...data highlighted the,efficacy and safety profile o...tment for patients with severe refractory chronic,...ists for severe Chronic Hand,Eczema (CHE) refracto...
...INESS WIRE)--May 21, 2007 - Gilead Sciences,Inc. ...term studies,evaluating ambrisentan, an investigat... treatment of patients with pulmonary,arterial hyp...ients,who originally participated in the two pivot... study of patients who had,previously discontinued...
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 2Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 3Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 4Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 5Gilead Announces Presentation of Long-Term Data for Ambrisentan, a,Potential Treatment for Patients With Pulmonary Arterial,Hypertension 6
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: